Latest round

Series A

Last raised

Jun 2024

Total raised

$15M

Investors

11

About Avalo

Based in North Carolina, US, and founded in 2020, Avalo, Inc. operates as a biotech company that helps plants adapt to different climates through gene discovery and control. In March 2025, Avalo, Inc. Avalo utilizes machine learning to accelerate plant production and crop development. It uses an AI-powered genome analysis that reduces the time and money it takes to breed hardier plants for hot temperatures. Avalo also uses molecular biology tools and works with partners to develop and produce new elite varieties. The company has built a model for simulating the effects of changes to a plant’s genome, which they claim can reduce that 15-year lead time to two or three and the cost by a similar ratio. Avalo plans to offer the data handling service to the more established companies like agriculture and pharmaceuticals and will be able to help bring a few of these plants into agriculture and become a seed provider as well.

Who invested in Avalo

11 investors across 3 rounds

See all investors in Avalo

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jun 27, 2024

    Amount

    $12M

    Investors

    Locked

  2. Seed

    Jul 9, 2021

    Amount

    $2.9M

    Investors

    Locked

  3. Seed

    Mar 8, 2021

    Amount

    Undisclosed

    Investors

    Locked

Questions about Avalo

Who invested in Avalo?

Avalo has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Avalo raised?

Avalo has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Avalo last raise money?

Avalo's most recent round on record is a Series A, in Jun 2024.

What does Avalo do?

Based in North Carolina, US, and founded in 2020, Avalo, Inc.

Where is Avalo headquartered?

Avalo is headquartered in US.

Which VCs invest in companies like Avalo?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Avalo's stage. Their profiles are linked below.

Raising like Avalo? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.